Gavrilova, EkaterinaWehringer, Mark2025-02-262025-02-262024-01-152023-01-15http://hdl.handle.net/10362/179847This thesis examines the Pfizer-Seagen acquisition, a pivotal deal in the pharmaceutical industry. It starts with a literature review on valuation methods and further analyses the strategic motivations and financial implications of mergers and acquisitions in the industry. The thesis assesses both companies' market positions, strategies, and financial health, to perform two comprehensive standalone valuations. It also conducts a combined valuation to explore potential synergies and economically feasible offer prices, comparing these to Pfizer's announced offer. Additionally, the thesis analyses the factors influencing premiums in M&As and stock reactions post-announcement in R&D intensive industries.engMerger and acquisitionsValuationPharmaceutical industryPfizerSeagenmaster thesis203866177